Novel inhibition of cis/trans retinoic acid interconversion in biological fluids -: an accurate method for determination of trans and 13-cis retinoic acid in biological fluids

被引:13
|
作者
Wang, CJ
Pao, LH
Hsiong, CH
Wu, CY
Whang-Peng, JJK
Hu, OYP
机构
[1] Natl Def Med Ctr, NeiHu, Taipei 11490, Taiwan
[2] Natl Hlth Res Inst, Canc Res Ctr, Taipei, Taiwan
[3] Natl Def Med Ctr, Pharmaceut Res Inst, Taipei 11490, Taiwan
[4] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 796卷 / 02期
关键词
interconversion; pharmacokinetics; retinoic acid;
D O I
10.1016/S1570-0232(03)00572-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0 ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25 degreesC were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150 muM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000 ng/ml) and 13-cRA (5-800 ng/ml) in plasma showed good linearity (r(2) = 0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000 ng/ml and 5 to 800 ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5 ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45 mg/m(2) per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [11] The Influence of 13-cis Retinoic Acid on Human Meibomian Gland Epithelial Cells
    Ding, Juan
    Kam, Wendy R.
    Dieckow, Julia
    Sullivan, David A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (06) : 4341 - 4350
  • [12] An enzymatic mechanism for generating the precursor of endogenous 13-cis retinoic acid in the brain
    Takahashi, Yusuke
    Moiseyev, Gennadiy
    Chen, Ying
    Farjo, Krysten
    Nikolaeva, Olga
    Ma, Jian-Xing
    FEBS JOURNAL, 2011, 278 (06) : 973 - 987
  • [13] Rapid measurement of retinol, retinal, 13-cis-retinoic acid and all-trans-retinoic acid by high performance liquid chromatography
    Tatum, V
    Chow, CK
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2005, 13 (03) : 256 - 259
  • [14] Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients
    Vikram Gota
    Girish Chinnaswamy
    Tushar Vora
    Sanhita Rath
    Akanksha Yadav
    Murari Gurjar
    Gareth Veal
    Purna Kurkure
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 763 - 768
  • [15] 13-cis retinoic acid and isomerisation in paediatric oncology -: is changing shape the key to success?
    Armstrong, JL
    Redfern, CPF
    Veal, GJ
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (09) : 1299 - 1306
  • [16] Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide
    Milanovic, Dusan
    Maier, Patrick
    Lohr, Frank
    Wenz, Frederik
    Herskind, Carsten
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (06) : 1205 - 1211
  • [17] SEPARATION OF 13-CIS AND ALL-TRANS-RETINOIC ACID AND THEIR PHOTODEGRADATION PRODUCTS USING CAPILLARY ZONE ELECTROPHORESIS AND MICELLAR ELECTROKINETIC CHROMATOGRAPHY (MEC)
    BEMPONG, DK
    HONIGBERG, IL
    MELTZER, NM
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (09) : 829 - 833
  • [18] Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid
    Halakos, Effie G.
    Connell, Andrew J.
    Glazewski, Lisa
    Wei, Shuo
    Mason, Robert W.
    JOURNAL OF PROTEOMICS, 2019, 209
  • [19] Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)
    Spiller, Susan E.
    Ditzler, Sally H.
    Pullar, Barbara J.
    Olson, James M.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (02) : 133 - 141
  • [20] Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients
    Gota, Vikram
    Chinnaswamy, Girish
    Vora, Tushar
    Rath, Sanhita
    Yadav, Akanksha
    Gurjar, Murari
    Veal, Gareth
    Kurkure, Purna
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 763 - 768